Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Dis Esophagus ; 23(2): 83-93, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19549210

RESUMO

Barrett's esophagus (BE) is a premalignant condition associated with the development of esophageal adenocarcinoma (EAC). Previous studies have implicated hydrophobic bile acids and gastric acid in BE and EAC pathogenesis. In this study, we tested the hypothesis that DNA damage, cytotoxicity and oxidative stress induced by bile acids and gastric acid can be attenuated by the cytoprotective, hydrophilic bile acid glycoursodeoxycholic acid (GUDCA). Non-dysplastic BE cells were exposed for 10 min to pH 4 and/or bile acid cocktail or to pH 4 and a modified cocktail consisting of a mixture of bile acids and GUDCA. DNA damage was evaluated by the comet assay; cell viability and proliferation were measured by trypan blue staining and the MTS assay; reactive oxygen species (ROS) were measured using hydroethidium staining; oxidative DNA/RNA damage was detected by immunostaining with antibody against 8-OH-dG; thiol levels were measured by 5-chloromethylfluorescein diacetate (CMFDA) staining; and the expression of antioxidant proteins was evaluated by western blotting. DNA damage and oxidative stress were significantly increased, while thiol levels were decreased in BE cells treated with pH 4 and bile acid cocktail compared with cells treated with pH 4 alone or untreated cells. Bile acids and low pH also significantly decreased cell proliferation. Expression of the antioxidant enzymes, MnSOD and CuZnSOD, was elevated in the cells treated with bile acids and low pH. When GUDCA was included in the medium, all these effects of pH 4 and bile acids were markedly reduced. In conclusion, treatment of BE cells with acidified medium and a bile acid cocktail at physiologically relevant concentrations induces DNA damage, cytotoxicity, and ROS. The cytoprotective bile acid, GUDCA, inhibits these deleterious effects by inhibiting oxidative stress.


Assuntos
Esôfago de Barrett/patologia , Citoproteção/efeitos dos fármacos , Substâncias Protetoras/farmacologia , Ácido Ursodesoxicólico/análogos & derivados , 8-Hidroxi-2'-Desoxiguanosina , Antioxidantes/análise , Ácidos e Sais Biliares/efeitos adversos , Linhagem Celular , Proliferação de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Dano ao DNA/efeitos dos fármacos , Ácido Desoxicólico/efeitos adversos , Desoxiguanosina/análogos & derivados , Desoxiguanosina/análise , Esôfago/efeitos dos fármacos , Esôfago/patologia , Sequestradores de Radicais Livres/análise , Ácido Glicoquenodesoxicólico/efeitos adversos , Ácido Glicocólico/efeitos adversos , Ácido Glicodesoxicólico/efeitos adversos , Humanos , Concentração de Íons de Hidrogênio , Estresse Oxidativo/efeitos dos fármacos , RNA/efeitos dos fármacos , Espécies Reativas de Oxigênio/análise , Compostos de Sulfidrila/análise , Superóxido Dismutase/análise , Ácido Taurocólico/efeitos adversos , Fatores de Tempo , Ácido Ursodesoxicólico/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...